SEC Form 3 · accession 0001683168-26-007216
Valion Bio, Inc. · VBIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas Jensen
Director
Period of report
Aug 27, 2026
Accepted (ET)
Sep 17, 2026 · 4:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001787740
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
No Table II lines on this filing.
Remarks
Exhibit 24.1 - Power of Attorney